Evidence map›Paper›PMID 41114856›Full record

ArticleIntensive care medicine experimental2025

Correction: Development and validation of a machine learning model for early prediction of intensive care unit acquired weakness.

Felipe Kenji Nakano, Nathalie Van Aerde, Gregoire Coppens, Ilse Vanhorebeek, Celine Vens, Greet Van den Berghe, Fabian Guiza Grandas

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Intensive care medicine experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Felipe Kenji Nakano *Department of Public Health and Primary Care, KU Leuven KULAK, Etienne Sabbelaan 53, 8500, Kortrijk, Belgium. felipekenji.nakano@kuleuven.be.
Nathalie Van Aerde *Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, KU Leuven, UZ, Herestraat 49, 3000, Louvain, Belgium.
Gregoire CoppensDepartment of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, KU Leuven, UZ, Herestraat 49, 3000, Louvain, Belgium.
Ilse VanhorebeekDepartment of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, KU Leuven, UZ, Herestraat 49, 3000, Louvain, Belgium.
Celine Vens *Department of Public Health and Primary Care, KU Leuven KULAK, Etienne Sabbelaan 53, 8500, Kortrijk, Belgium.
Greet Van den Berghe *Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, KU Leuven, UZ, Herestraat 49, 3000, Louvain, Belgium.
Fabian Guiza Grandas *Department of Cellular and Molecular Medicine, Clinical Division and Laboratory of Intensive Care Medicine, KU Leuven, UZ, Herestraat 49, 3000, Louvain, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41114856
PMCPMC12537630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.